HCKT vs PAYS

HCKT exhibits a dichotomy between strong operational health and poor market performance, highlighted by a strong Piotroski F-Score of 7/9 but a catastrophic 1-year price decline of 51.5%. While earnings growth is robust (64.6% YoY), this is decoupled from revenue, which is contracting (-3.4% YoY), suggesting profitability is driven by cost-cutting rather than organic growth. The dividend is a significant red flag with a payout ratio of 104.35%, rendering it unsustainable. The stock currently trades near its growth-based intrinsic value of $13.57, though it remains well above its defensive Graham Number of $5.3.

PAYS exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is currently trading at a severe premium to its deterministic value (Graham Number: $1.60, Intrinsic Value: $0.91). While revenue growth is explosive at 45.8%, this has not yet translated into bottom-line earnings growth, which remains slightly negative (-3.60%). The stock has experienced a parabolic 1-year run (+179.4%), leading to a high trailing P/E of 44.92, though the Forward P/E of 15.07 suggests significant expected earnings acceleration. Overall, the company is fundamentally healthy but valuationally overextended.